# Limited Population Pathway for Antibacterial and Antifungal Drugs Guidance for Industry - FDA Guidance Document

Source: https://www.globalkeysolutions.net/guidances/guidance-document/limited-population-pathway-for-antibacterial-and-antifungal-drugs-guidance-for-industry/f01d33af-ed26-4eb5-961a-03e00c90f2c7

> FDA guidance document: Limited Population Pathway for Antibacterial and Antifungal Drugs Guidance for Industry. Issue date: August 05, 2020. Get complete insights and analysis.

---

## Details

- Title: Limited Population Pathway for Antibacterial and Antifungal Drugs Guidance for Industry
- Communication Type: Guidance Document
- Product Type: biologics
- Office Name: Center for Drug Evaluation and Research
- Office URL: /offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c
- Issue Date: 2020-08-05
- Last Changed: 2020-08-05
- Docket Number: <a href="https://www.regulations.gov/docket/FDA-2018-D-2032">FDA-2018-D-2032</a>

## Related Documents

- [M12 Drug Interaction Studies](https://www.globalkeysolutions.net/guidances/guidance-document/m12-drug-interaction-studies/2ca5aef5-80cc-464b-ba2c-bd69d35dfc2d)
- [Bacterial Vaginosis: Developing Drugs for Treatment Guidance for Industry](https://www.globalkeysolutions.net/guidances/guidance-document/bacterial-vaginosis-developing-drugs-for-treatment-guidance-for-industry/d280b63f-a1bf-46b4-aa9d-41f650dd1b70)
- [Qualification Process for Drug Development Tools Guidance for Industry and FDA Staff](https://www.globalkeysolutions.net/guidances/guidance-document/qualification-process-for-drug-development-tools-guidance-for-industry-and-fda-staff/f5a3f8af-54f6-44ba-9eea-d3cc587444f7)